KEY FEATURES
Full Name | Glucagon |
---|---|
Synonym | GC; GLP1; GLP2; GRPP; Glicentin-Related Polypeptide; Glucagen; Oxyntomodulin; Incretin hormone |
Assay Type | Competitive |
Reactivity | Universal |
Range | 18.52-1500pg/mL |
Sensitivity | 6.94pg/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 50μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected GCG in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Competitive-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with GCG. During the reaction, GCG in the sample or standard competes with a fixed amount of GCG on the solid phase supporter for sites on the Biotinylated Detection Ab specific to GCG. Excess conjugate and unbound sample or standard are washed away, and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns from blue to yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of GCG in tested samples can be calculated by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

GCG ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 82.04 | 166.18 | 650.68 | 87.08 | 155.18 | 683.99 |
Standard deviation | 4.96 | 9.87 | 28.5 | 5.09 | 6.61 | 22.16 |
CV(%) | 6.04 | 5.94 | 4.38 | 5.84 | 4.26 | 3.24 |
RECOVERY
The recovery of GCG spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 94-109 | 101 |
EDTA plasma (n=8) | 93-109 | 99 |
Cell culture media (n=8) | 94-110 | 100 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of GCG in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with GLP-1 ELISA Kits
GLP1R ELISA Kit | publications with GLP-1 and GLP1R |
GCGR ELISA Kit | publications with GLP-1 and GCGR |
GLP2R ELISA Kit | publications with GLP-1 and GLP2R |
Pathways associated with GLP-1 ELISA Kit
Class B/2 (Secretin Family Receptors) Pathway | Class B/2 (Secretin Family Receptors) Pathway |
FOXA1 Transcription Factor Network Pathway | FOXA1 Transcription Factor Network Pathway |
G Alpha (q) Signalling Events Pathway | G Alpha (q) Signalling Events Pathway |
G Alpha (s) Signalling Events Pathway | G Alpha (s) Signalling Events Pathway |
GPCR Downstream Signaling Pathway | GPCR Downstream Signaling Pathway |
GPCR Ligand Binding Pathway | GPCR Ligand Binding Pathway |
Gastrin-CREB Signalling Pathway Via PKC And MAPK | Gastrin-CREB Signalling Pathway Via PKC And MAPK |
Glucagon Signaling In Metabolic Regulation Pathway | Glucagon Signaling In Metabolic Regulation Pathway |
Glucagon-type Ligand Receptors Pathway | Glucagon-type Ligand Receptors Pathway |
Incretin Synthesis, Secretion, And Inactivation Pathway | Incretin Synthesis, Secretion, And Inactivation Pathway |
Diseases associated with GLP-1 ELISA Kit
Muscular Diseases | publications with GLP-1 and Muscular Diseases |
Diabetes Mellitus | publications with GLP-1 and Diabetes Mellitus |
Vascular Diseases | publications with GLP-1 and Vascular Diseases |
Kidney Diseases | publications with GLP-1 and Kidney Diseases |
Obesity | publications with GLP-1 and Obesity |
Insulin Resistance | publications with GLP-1 and Insulin Resistance |
Hyperglycemia | publications with GLP-1 and Hyperglycemia |
Heart Diseases | publications with GLP-1 and Heart Diseases |
Liver Diseases | publications with GLP-1 and Liver Diseases |
Drug Toxicity | publications with GLP-1 and Drug Toxicity |
Organs/Tissues associated with GLP-1 ELISA Kit
Pancreas | publications with GLP-1 and Pancreas |
Intestine | publications with GLP-1 and Intestine |